$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO

Biochemical pharmacology, v.82 no.9, 2011년, pp.1163 - 1174  

Chiaravalli, Jeanne (Institut Pasteur, Unité) ,  Fontan, Elisabeth (de Biochimie Structurale et Cellulaire, CNRS, URA 2185, France) ,  Fsihi, Hafida (Institut Pasteur, Unité) ,  Coic, Yves-Marie (de Biochimie Structurale et Cellulaire, CNRS, URA 2185, France) ,  Baleux, Françoise (Institut Pasteur, Unité) ,  Véron, Michel (de Biochimie Structurale et Cellulaire, CNRS, URA 2185, France) ,  Agou, Fabrice (Institut Pasteur, Unité)

Abstract AI-Helper 아이콘AI-Helper

Graphical abstract AbstractAberrant and constitutive NF-κB activation are frequently reported in numerous tumor types, making its inhibition an attractive target for the treatment of certain cancers. NEMO (NF-κB essential modulator) is the crucial component of the canonical NF-κB p...

주제어

참고문헌 (67)

  1. Cell Hayden 132 344 2008 10.1016/j.cell.2008.01.020 Shared principles in NF-kappaB signaling 

  2. Nat Rev Mol Cell Biol Perkins 8 49 2007 10.1038/nrm2083 Integrating cell-signalling pathways with NF-kappaB and IKK function 

  3. Oncogene Scheidereit 25 6685 2006 10.1038/sj.onc.1209934 IkappaB kinase complexes: gateways to NF-kappaB activation and transcription 

  4. Annu Rev Immunol Vallabhapurapu 27 693 2009 10.1146/annurev.immunol.021908.132641 Regulation and function of NF-kappaB transcription factors in the immune system 

  5. Nat Immunol Sato 6 1087 2005 10.1038/ni1255 Essential function for the kinase TAK1 in innate and adaptive immune responses 

  6. Genes Dev Shim 19 2668 2005 10.1101/gad.1360605 TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo 

  7. Nat Struct Mol Biol Kulathu 16 1328 2009 10.1038/nsmb.1731 Two-sided ubiquitin binding explains specificity of the TAB2 NZF domain 

  8. EMBO J Sato 28 2461 2009 10.1038/emboj.2009.160 Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by tandem UIMs of RAP80 

  9. Nat Cell Biol Tokunaga 11 123 2009 10.1038/ncb1821 Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation 

  10. Nature Gerlach 471 591 2011 10.1038/nature09816 Linear ubiquitination prevents inflammation and regulates immune signalling 

  11. Nature Ikeda 471 637 2011 10.1038/nature09814 SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappaB activity and apoptosis 

  12. Nature Tokunaga 471 633 2011 10.1038/nature09815 SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex 

  13. Mol Cell Haas 36 831 2009 10.1016/j.molcel.2009.10.013 Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction 

  14. Mol Cell Xu 36 302 2009 10.1016/j.molcel.2009.10.002 A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta 

  15. Nature Xia 461 114 2009 10.1038/nature08247 Direct activation of protein kinases by unanchored polyubiquitin chains 

  16. Mol Cell Biol Marienfeld 26 9209 2006 10.1128/MCB.00478-06 Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity 

  17. Structure Rushe 16 798 2008 10.1016/j.str.2008.02.012 Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site 

  18. Mol Cell Bagneris 30 620 2008 10.1016/j.molcel.2008.04.029 Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome 

  19. J Mol Biol Grubisha 395 89 2010 10.1016/j.jmb.2009.10.018 DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding 

  20. J Biol Chem Agou 279 54248 2004 10.1074/jbc.M406423200 Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization 

  21. FEBS Lett Heyninck 536 135 2003 10.1016/S0014-5793(03)00041-3 Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1 

  22. Trends Cell Biol Sebban 16 569 2006 10.1016/j.tcb.2006.09.004 Posttranslational modifications of NEMO and its partners in NF-kappaB signaling 

  23. Oncogene Wagner 27 3739 2008 10.1038/sj.onc.1211042 Ubiquitin binding mediates the NF-kappaB inhibitory potential of ABIN proteins 

  24. Mol Cell Ea 22 245 2006 10.1016/j.molcel.2006.03.026 Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO 

  25. Nat Cell Biol Wu 8 398 2006 10.1038/ncb1384 Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation 

  26. Mol Cell Lo 33 602 2009 10.1016/j.molcel.2009.01.012 Structural basis for recognition of diubiquitins by NEMO 

  27. Cell Rahighi 136 1098 2009 10.1016/j.cell.2009.03.007 Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation 

  28. FEBS Lett Yoshikawa 583 3317 2009 10.1016/j.febslet.2009.09.028 Crystal structure of the NEMO ubiquitin-binding domain in complex with Lys 63-linked di-ubiquitin 

  29. J Mol Biol Cordier 377 1419 2008 10.1016/j.jmb.2008.01.048 Solution structure of NEMO zinc-finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation 

  30. J Biol Chem Cordier 284 2902 2009 10.1074/jbc.M806655200 The zinc finger of NEMO is a functional ubiquitin-binding domain 

  31. EMBO J Laplantine 28 2885 2009 10.1038/emboj.2009.241 NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain 

  32. Nat Rev Drug Discov Baud 8 33 2009 10.1038/nrd2781 Is, NF-kappaB a good target for cancer therapy? Hopes and pitfalls 

  33. Nat Rev Immunol Karin 5 749 2005 10.1038/nri1703 NF-kappaB: linking inflammation and immunity to cancer development and progression 

  34. Cell Death Differ Kim 13 738 2006 10.1038/sj.cdd.4401877 IKK as therapeutic targets in cancer 

  35. Cell Death Differ Legarda-Addison 16 1279 2009 10.1038/cdd.2009.41 NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling 

  36. Blood Nagashima 107 4266 2006 10.1182/blood-2005-09-3852 Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta 

  37. Nat Genet Doffinger 27 277 2001 10.1038/85837 X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling 

  38. Proc Natl Acad Sci USA Bloor 105 1279 2008 10.1073/pnas.0706552105 Signal processing by its coil zipper domain activates IKK gamma 

  39. Oncogene Harhaj 19 1448 2000 10.1038/sj.onc.1203445 Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein 

  40. FEBS J Fontan 274 2540 2007 10.1111/j.1742-4658.2007.05788.x NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex 

  41. Biochemistry Mousson 41 13611 2002 10.1021/bi026274b Deciphering the role of individual acyl chains in the interaction network between phosphatidylserines and a single-spanning membrane protein 

  42. Mol Cell Biol Courtois 17 1441 1997 10.1128/MCB.17.3.1441 Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli 

  43. J Biol Chem Agou 279 27861 2004 10.1074/jbc.M314278200 The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains 

  44. Protein Sci Wyler 16 2013 2007 10.1110/ps.072924907 Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO 

  45. Br J Pharmacol Jones 145 1093 2005 10.1038/sj.bjp.0706279 Characterisation of cell-penetrating peptide-mediated peptide delivery 

  46. Adv Drug Deliv Rev Wadia 57 579 2005 10.1016/j.addr.2004.10.005 Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer 

  47. Nat Rev Mol Cell Biol Sharrocks 2 827 2001 10.1038/35099076 The ETS-domain transcription factor family 

  48. Oncogene Mechta-Grigoriou 20 2378 2001 10.1038/sj.onc.1204381 The mammalian Jun proteins: redundancy and specificity 

  49. Cell Crabtree 109 Suppl. S67 2002 10.1016/S0092-8674(02)00699-2 NFAT signaling: choreographing the social lives of cells 

  50. Cell Death Differ Papa 13 712 2006 10.1038/sj.cdd.4401865 The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease 

  51. Expert Opin Drug Deliv Bidwell 6 1033 2009 10.1517/17425240903143745 Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades 

  52. Nature Moellering 462 182 2009 10.1038/nature08543 Direct inhibition of the NOTCH transcription factor complex 

  53. Curr Opin Genet Dev Prive 16 71 2006 10.1016/j.gde.2005.12.010 Specific peptides for the therapeutic targeting of oncogenes 

  54. Expert Opin Drug Deliv Raucher 6 1049 2009 10.1517/17425240903158909 Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides 

  55. EMBO J Sato 28 3903 2009 10.1038/emboj.2009.345 Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3 

  56. Biochemistry Acharya 45 11324 2006 10.1021/bi060822u Stability of 100 homo and heterotypic coiled-coil a-a’ pairs for ten amino acids (A, L, I, V, N, K, S, T, E, and R) 

  57. Curr Opin Struct Biol Grigoryan 18 477 2008 10.1016/j.sbi.2008.04.008 Structural specificity in coiled-coil interactions 

  58. Proc Natl Acad Sci USA Kammerer 95 13419 1998 10.1073/pnas.95.23.13419 An autonomous folding unit mediates the assembly of two-stranded coiled coils 

  59. J Mol Biol Myers 289 205 1999 10.1006/jmbi.1999.2747 Reinterpretation of GCN4-p1 folding kinetics: partial helix formation precedes dimerization in coiled coil folding 

  60. Proc Natl Acad Sci USA Steinmetz 104 7062 2007 10.1073/pnas.0700321104 Molecular basis of coiled-coil formation 

  61. Mol Cell Bertrand 30 689 2008 10.1016/j.molcel.2008.05.014 cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination 

  62. J Biol Chem Varfolomeev 283 24295 2008 10.1074/jbc.C800128200 c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation 

  63. Cell Deng 103 351 2000 10.1016/S0092-8674(00)00126-4 Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain 

  64. Biochemistry Yin 48 10558 2009 10.1021/bi901462e Structural basis for the lack of E2 interaction in the RING domain of TRAF2 

  65. Nat Struct Mol Biol Yin 16 658 2009 10.1038/nsmb.1605 E2 interaction and dimerization in the crystal structure of TRAF6 

  66. FEBS Lett Park 566 151 2004 10.1016/j.febslet.2004.04.021 Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro 

  67. Science May 289 1550 2000 10.1126/science.289.5484.1550 Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로